Literature DB >> 19464190

Synthesis and biological activity of a fluorescent schweinfurthin analogue.

Craig H Kuder1, Jeffrey D Neighbors, Raymond J Hohl, David F Wiemer.   

Abstract

Most of the natural schweinfurthins are potent and selective inhibitors of cell growth as measured by the National Cancer Institute's 60-cell line screen. Due to the limited supply of these natural products, we have initiated a program aimed at their synthesis. To date, this effort has led to the preparation of three natural schweinfurthins and more than 40 analogues, and assays on these compounds have afforded some understanding of structure-activity relationships in this family. Further development of schweinfurthins as chemotherapeutic agents would benefit from characterization of their mechanism(s) of action. This perspective led to development of a fluorescent schweinfurthin analogue that retains the differential activity of the natural products, and yet has properties that facilitate its visualization within cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464190      PMCID: PMC6685536          DOI: 10.1016/j.bmc.2009.04.071

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  Pleiotropic effects of a schweinfurthin on isoprenoid homeostasis.

Authors:  Sarah A Holstein; Craig H Kuder; Huaxiang Tong; Raymond J Hohl
Journal:  Lipids       Date:  2011-06-02       Impact factor: 1.880

2.  Fluorescent schweinfurthin B and F analogs with anti-proliferative activity.

Authors:  Joseph J Topczewski; Craig H Kuder; Jeffrey D Neighbors; Raymond J Hohl; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2010-07-29       Impact factor: 3.641

3.  The synthesis, X-ray crystal structure and optical properties of novel 5-aryl-3-ferrocenyl-1-pyridazinyl-pyrazoline derivatives.

Authors:  Zhong-Liang Gong; Yong-Sheng Xie; Bao-Xiang Zhao; Hong-Shui Lv; Wei-Yong Liu; Liang-Wen Zheng; Song Lian
Journal:  J Fluoresc       Date:  2010-10-02       Impact factor: 2.217

4.  Synthesis of indole analogues of the natural schweinfurthins.

Authors:  John G Kodet; David F Wiemer
Journal:  J Org Chem       Date:  2013-09-05       Impact factor: 4.354

5.  Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity.

Authors:  Kathleen M Kokolus; Jeremy S Haley; Emily J Koubek; Raghavendra Gowda; Saketh S Dinavahi; Arati Sharma; David F Claxton; Klaus F Helm; Joseph J Drabick; Gavin P Robertson; Jeffrey D Neighbors; Raymond J Hohl; Todd D Schell
Journal:  Oncoimmunology       Date:  2018-11-11       Impact factor: 8.110

6.  Relevance of the C-5 position to schweinfurthin induced cytotoxicity.

Authors:  Joseph J Topczewski; Michael P Callahan; John G Kodet; Jery D Inbarasu; Nolan R Mente; John A Beutler; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2011-10-19       Impact factor: 3.641

7.  First total synthesis of (+)-Vedelianin, a potent antiproliferative agent.

Authors:  Joseph J Topczewski; David F Wiemer
Journal:  Tetrahedron Lett       Date:  2011-04-06       Impact factor: 2.415

8.  Exploration of cascade cyclizations terminated by tandem aromatic substitution: total synthesis of (+)-schweinfurthin A.

Authors:  Joseph J Topczewski; John G Kodet; David F Wiemer
Journal:  J Org Chem       Date:  2011-01-12       Impact factor: 4.354

9.  Functional evaluation of a fluorescent schweinfurthin: mechanism of cytotoxicity and intracellular quantification.

Authors:  Craig H Kuder; Ryan M Sheehy; Jeffrey D Neighbors; David F Wiemer; Raymond J Hohl
Journal:  Mol Pharmacol       Date:  2012-03-29       Impact factor: 4.436

10.  3-Deoxyschweinfurthin B Lowers Cholesterol Levels by Decreasing Synthesis and Increasing Export in Cultured Cancer Cell Lines.

Authors:  Craig H Kuder; Megan M Weivoda; Ying Zhang; Junjia Zhu; Jeffrey D Neighbors; David F Wiemer; Raymond J Hohl
Journal:  Lipids       Date:  2015-10-22       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.